Abstract:Study Description: Patients will have a 1:1 randomization to receive subcutaneous electrical nerve stimulation (ScNS) to observe if the stimulation can reduce atrial fibrillation burden in patients with symptomatic atrial fibrillation (AF). All subjects will undergo the implant of a neurostimulator lead. The experimental group will receive stimulation and the control group will not receive stimulation. All subjects will complete the same follow up visits to compare the 2 groups Objectives: Primary Objective: To test the hypothesis that chronic subcutaneous nerve stimulation can reduce AF burden in patients with severe symptomatic AF unresponsive to conventional therapies The secondary objective: To test the hypotheses that the effect of ScNS on the following endpoints is different between the two randomization groups: 1) Time-dependent reduction of AF burden 2) Effects of ScNS on ventricular rate control during AF Endpoints: Primary Objective: To test the hypothesis that chronic subcutaneous nerve stimulation can reduce AF burden in patients with severe symptomatic AF unresponsive to conventional therapies The secondary objective: To test the hypotheses that the effect of ScNS on the following endpoints is different between the two randomization groups: 1) Time-dependent reduction of AF burden 2) Effects of ScNS on ventricular rate control during AF 3) Reduction of SKNA 4) Improvement of quality of life •The primary Efficacy Endpoint: The average AF burden. •The secondary Efficacy Endpoint(s): 1) Time-dependent reduction of AF burden 2) Ventricular rate during AF 3) average SKNA 4) Quality of life Study Population: The study will enroll patients with symptomatic atrial fibrillation unresponsive to conventional therapy defined by not responding to at least 1 antiarrhythmic drug.The study will enroll 30 patients, including 15 men and 15 women between the 18 and 75 years old. There will be no sex/gender/racial/ethnic based exclusion. Patients will be enrolled from the Cedars Sinai Medical Center. Phase: Not applicable Description of Sites/Facilities Enrolling Participants: The study will enroll patients treated at the Cedars-Sinai Medical Center. This is a single site study. Description of Study Intervention: The patients will undergo surgical implantation of an externalized lead under the skin on the chest wall. The wire is then connected to a neurostimulator. The experimental group (Group A) will receive ScNS (3.5 mA) for two weeks. The shame group (Group B) will receive sham (0 mA) stimulation for two weeks. The AF burden will be assessed by a 7-day mobile cardiac telemetry. Study Duration: 36 months Participant Duration: Up to 4 months.

Using subcutaneous nerve stimulation for rate control of atrial fibrillation v1

Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation.

Rationale and Study Design for Evaluating the Efficacy and Safety of Intracardiac Echocardiography-Guided Minimal-Fluoroscopy Ablation in Patients with Paroxysmal Atrial Fibrillation: A Non-Inferior, Multi-Center, Prospective Randomized Controlled Trial (PAF-ICE Trial)

TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial

A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation

Circumferential Pulmonary Vein Isolation Plus Low-Voltage Area Modification in Persistent Atrial Fibrillation

STABLE-SR (electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm) for the Treatment of Nonparoxysmal Atrial Fibrillation A Prospective, Multicenter Randomized Clinical Trial

Acupuncture for Persistent Atrial Fibrillation after Catheter Ablation: Study Protocol for a Pilot Randomized Controlled Trial

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation

Atrial autonomic denervation for the treatment of long-standing symptomatic sinus bradycardia in non-elderly patients

Effect of acupuncture on quality of life in atrial fibrillation: study protocol for a randomised controlled trial

Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial

Targeted ablation of epicardial ganglionated plexi during cardiac surgery with pulsed field electroporation (NEURAL AF)

Continuous vagal nerve stimulation affects atrial neural remodeling and reduces atrial fibrillation inducibility in rabbits

Effect of sacubitril/valsartan on sinus rhythm maintenance after catheter ablation in patients with persistent atrial fibrillation without reduced ejection fraction heart failure: a study protocol for a multi-center, open-label, randomized, controlled, superiority clinical trial

Insertable cardiac monitor-guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM-REDUCE-AF trial)

Abstract 315: Feasibility of outpatient ambulatory ECG monitoring to screen for silent atrial fibrillation: Pilot Findings from Screening Trial for Undiagnosed Atrial Fibrillation (STUDY-AF)

Optimal Rhythm-Control Strategy for Recurrent Atrial Tachycardia after Catheter Ablation of Persistent Atrial Fibrillation: a Randomized Clinical Trial

Multi-centre, Prospective Randomized Comparison of Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation

Long-Term Observation Of Catheter Ablation Vs. Pharmacotherapy In The Management Of Persistent And Long-Standing Persistent Atrial Fibrillation (Capa Study)